Interferon-α2b/ribavirin (REBETRON®) treatment for chronic hepatitis C -: Population pharmacokinetics and pharmacodynamics of ribavirin.

被引：0
|
作者：
Glue, P [1 ]
Jen, F [1 ]
Gupta, SK [1 ]
Lau, G [1 ]
机构：
[1] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
119
引用
收藏
页码：190A / 190A
页数：1
相关论文
共 50 条
  • [31] Continuous interferon-α2b infusion in combination with ribavirin for chronic hepatitis C in treatment-experienced patients
    Roomer, Robert
    Bergmann, Jilling F.
    Boonstra, Andre
    Hansen, Bettina E.
    Haagmans, Bart L.
    Kwadijk-de Gijsel, Sonja
    van Vuuren, Anneke J.
    de Knegt, Robert J.
    Janssen, Harry L. A.
    ANTIVIRAL THERAPY, 2012, 17 (03) : 509 - 517
  • [32] Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C
    Siebert, U
    Sroczynski, G
    Rossol, S
    Wasem, J
    Ravens-Sieberer, U
    Kurth, BM
    Manns, MP
    McHutchison, JG
    Wong, JB
    GUT, 2003, 52 (03) : 425 - 432
  • [33] Successful treatment of hepatitis C reinfection with interferon-α2b and ribavirin after liver transplantation
    Yedibela, S
    Schuppan, D
    Müller, V
    Schellerer, V
    Tannapfel, A
    Hohenberger, W
    Meyer, T
    LIVER INTERNATIONAL, 2005, 25 (04) : 717 - 722
  • [34] Treatment of chronic hepatitis C with interferon alpha and ribavirin. Results in "real life"
    Pariente, A
    Djilloul, A
    Cadranel, JF
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2003, 27 (6-7): : 590 - 595
  • [35] Treatment with ribavirin and interferon-α reduces interferon-γ expression in patients with chronic hepatitis C
    Bergamini, A
    Bolacchi, F
    Cepparulo, M
    Demin, F
    Uccella, I
    Bongiovanni, B
    Ombres, D
    Angelico, F
    Liuti, A
    Hurtova, M
    Francioso, S
    Carvelli, C
    Cerasari, G
    Angelico, M
    Rocchi, G
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 123 (03): : 459 - 464
  • [36] Interferon-α-2b+ribavirin for the treatment of chronic hepatitis C in non-responders to interferon-α-monotherapy
    Tromm, A
    Greving, I
    Griga, T
    Mankel, K
    Hüppe, D
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2000, 38 (02): : 159 - 164
  • [37] Ribavirin and interferon-α-2b combination treatment of chronic hepatitis C in patients with haemophilia and other clotting disorders.
    Fried, R
    Meili, E
    Peter, K
    Hartmann, S
    Tsakiris, D
    Fried, C
    Egger, H
    Zanni, M
    Marbet, G
    GASTROENTEROLOGY, 1999, 116 (04) : A1212 - A1212
  • [38] Interferon-α-2b/ribavirin-induced vestibulocochlear toxicity with dysautonomia in a chronic hepatitis C patient
    Johnson, Kristin
    Sargent, Lisa A.
    Galizio, Christopher
    Ubogu, Eroboghene E.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (11) : 1110 - 1114
  • [39] Late onset autoimmune thrombocytopenia associated with pegylated interferon-α-2b plus ribavirin treatment for chronic hepatitis C
    Elefsiniotis, IS
    Pantazis, KD
    Fotos, NV
    Moulakakis, A
    Mavrogiannis, C
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (03) : 622 - 623
  • [40] Response to pegylated interferon α-2b and ribavirin in children with chronic hepatitis C
    Baker, Robert D.
    Dee, Deborah
    Baker, Susan S.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2007, 41 (01) : 111 - 114
12345